Compare TTK HEALTHCARE with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE PANACEA BIOTECH TTK HEALTHCARE/
PANACEA BIOTECH
 
P/E (TTM) x 18.8 12.2 153.4% View Chart
P/BV x 1.5 2.9 51.1% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 TTK HEALTHCARE   PANACEA BIOTECH
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
PANACEA BIOTECH
Mar-18
TTK HEALTHCARE/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,215364 333.8%   
Low Rs610129 472.6%   
Sales per share (Unadj.) Rs444.496.8 459.1%  
Earnings per share (Unadj.) Rs17.2-12.4 -139.0%  
Cash flow per share (Unadj.) Rs27.6-2.9 -968.7%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs177.950.4 353.1%  
Shares outstanding (eoy) m14.1361.25 23.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.12.5 80.6%   
Avg P/E ratio x52.9-19.9 -266.3%  
P/CF ratio (eoy) x33.0-86.4 -38.2%  
Price / Book Value ratio x5.14.9 104.8%  
Dividend payout %29.00-   
Avg Mkt Cap Rs m12,89415,101 85.4%   
No. of employees `0002.32.5 93.7%   
Total wages/salary Rs m1,3071,516 86.2%   
Avg. sales/employee Rs Th2,715.72,401.9 113.1%   
Avg. wages/employee Rs Th565.3614.2 92.0%   
Avg. net profit/employee Rs Th105.4-307.9 -34.2%   
INCOME DATA
Net Sales Rs m6,2795,928 105.9%  
Other income Rs m7882 94.2%   
Total revenues Rs m6,3566,010 105.8%   
Gross profit Rs m496845 58.6%  
Depreciation Rs m147585 25.1%   
Interest Rs m341,006 3.4%   
Profit before tax Rs m393-664 -59.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m02 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m14999 151.0%   
Profit after tax Rs m244-760 -32.1%  
Gross profit margin %7.914.3 55.4%  
Effective tax rate %37.9-14.9 -255.2%   
Net profit margin %3.9-12.8 -30.3%  
BALANCE SHEET DATA
Current assets Rs m2,7175,603 48.5%   
Current liabilities Rs m1,5716,910 22.7%   
Net working cap to sales %18.3-22.0 -82.8%  
Current ratio x1.70.8 213.3%  
Inventory Days Days32206 15.6%  
Debtors Days Days4784 55.7%  
Net fixed assets Rs m9919,941 10.0%   
Share capital Rs m14161 230.5%   
"Free" reserves Rs m2,3733,026 78.4%   
Net worth Rs m2,5143,087 81.5%   
Long term debt Rs m35,707 0.1%   
Total assets Rs m4,15816,076 25.9%  
Interest coverage x12.60.3 3,706.9%   
Debt to equity ratio x01.8 0.1%  
Sales to assets ratio x1.50.4 409.5%   
Return on assets %6.71.5 436.5%  
Return on equity %9.7-24.6 -39.4%  
Return on capital %16.93.9 432.5%  
Exports to sales %3.624.0 14.9%   
Imports to sales %0.517.5 2.8%   
Exports (fob) Rs m2251,424 15.8%   
Imports (cif) Rs m311,040 3.0%   
Fx inflow Rs m2251,600 14.1%   
Fx outflow Rs m711,131 6.3%   
Net fx Rs m154469 32.9%   
CASH FLOW
From Operations Rs m1731,180 14.7%  
From Investments Rs m97553 17.5%  
From Financial Activity Rs m-307-1,644 18.7%  
Net Cashflow Rs m-3890 -42.0%  

Share Holding

Indian Promoters % 65.4 74.5 87.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 0.6 616.7%  
FIIs % 5.2 1.3 400.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 23.6 109.3%  
Shareholders   12,723 10,259 124.0%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   IPCA LABS  NOVARTIS  DR. DATSONS LABS  PROCTER & GAMBLE HEALTH  GSK PHARMA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

My 7 Stocks to Buy Are Companies Which Will Be a Big Part of New India(The 5 Minute Wrapup)

Sep 19, 2019

The India we knew is changing. Here's how you can benefit from this change.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Sep 20, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS